IL103478A0 - Therapeutic agent - Google Patents
Therapeutic agentInfo
- Publication number
- IL103478A0 IL103478A0 IL92103478A IL10347892A IL103478A0 IL 103478 A0 IL103478 A0 IL 103478A0 IL 92103478 A IL92103478 A IL 92103478A IL 10347892 A IL10347892 A IL 10347892A IL 103478 A0 IL103478 A0 IL 103478A0
- Authority
- IL
- Israel
- Prior art keywords
- therapeutic agent
- compound
- acridinedione
- cyanophenyl
- hexahydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/06—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919122305A GB9122305D0 (en) | 1991-10-21 | 1991-10-21 | Therapeutic agents |
| GB929213538A GB9213538D0 (en) | 1992-06-25 | 1992-06-25 | Therapeutic agent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL103478A0 true IL103478A0 (en) | 1993-03-15 |
Family
ID=26299722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL92103478A IL103478A0 (en) | 1991-10-21 | 1992-10-20 | Therapeutic agent |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5258390A (fi) |
| EP (1) | EP0539153B1 (fi) |
| JP (1) | JP3157924B2 (fi) |
| KR (1) | KR930007907A (fi) |
| AT (1) | ATE152103T1 (fi) |
| AU (1) | AU659500B2 (fi) |
| CA (1) | CA2080950A1 (fi) |
| CZ (1) | CZ317592A3 (fi) |
| DE (2) | DE69219271T2 (fi) |
| FI (1) | FI924744A (fi) |
| GB (1) | GB9220570D0 (fi) |
| HU (1) | HUT65626A (fi) |
| IL (1) | IL103478A0 (fi) |
| MY (1) | MY106661A (fi) |
| NO (1) | NO178696C (fi) |
| NZ (1) | NZ244822A (fi) |
| PL (1) | PL169716B1 (fi) |
| TW (1) | TW223061B (fi) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9214120D0 (en) * | 1991-07-25 | 1992-08-12 | Ici Plc | Therapeutic amides |
| ATE161531T1 (de) * | 1991-10-21 | 1998-01-15 | Zeneca Ltd | Acridine-1,8-dionderivate als therapeutisches mittel |
| US5455253A (en) * | 1992-10-20 | 1995-10-03 | Zeneca Limited | Heterocyclic derivatives |
| GB9318935D0 (en) * | 1992-10-20 | 1993-10-27 | Zeneca Ltd | Heterocyclic derivatives |
| GB9310069D0 (en) * | 1993-05-17 | 1993-06-30 | Zeneca Ltd | Heterocyclic compounds |
| GB9407432D0 (en) * | 1994-04-14 | 1994-06-08 | Zeneca Ltd | Heterocyclic derivative |
| WO1996027375A2 (en) | 1995-03-03 | 1996-09-12 | Algos Pharmaceutical Corporation | Use of dextromethorphan or dextrorphan for the treatment of urinary incontinence |
| GB9707695D0 (en) * | 1996-08-07 | 1997-06-04 | Hoffmann La Roche | Tricyclic dione derivatives |
| US7030096B1 (en) * | 1997-02-13 | 2006-04-18 | Albert Einstein College Of Medicine Of Yeshiva University | Method of enhancing relaxation of penile smooth muscle by introduction of DNA encoding maxi-K potassium channel protein |
| US6642222B2 (en) | 1998-10-28 | 2003-11-04 | Abbott Laboratories | Pyrano, piperidino, and thiopyrano compounds and methods of use |
| US6191140B1 (en) | 1998-10-28 | 2001-02-20 | Abbott Laboratories | Pyrano, piperidino, and thiopyrano compounds and methods of use |
| AU1459500A (en) * | 1998-10-28 | 2000-05-15 | Abbott Laboratories | Dihydropyridine compounds and methods of use |
| US6518279B2 (en) | 1999-03-04 | 2003-02-11 | Abbott Laboratories | Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| TWI287984B (en) * | 2000-10-17 | 2007-10-11 | Wyeth Corp | Pharmaceutical composition for modulating bladder function |
| AR033095A1 (es) | 2001-04-04 | 2003-12-03 | Wyeth Corp | Metodos para el tratamiento de motilidad gastrica hiperactiva |
| EP1688141A1 (en) | 2005-01-31 | 2006-08-09 | elbion AG | The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome |
| EP1896112A4 (en) | 2005-06-07 | 2011-04-27 | A M S Res Corp | INJECTION GUIDANCE SYSTEM AND METHOD |
| US7674793B2 (en) | 2006-02-10 | 2010-03-09 | Janssen Pharmaceutica Nv | Tricyclic dihydropyrazines as potassium channel openers |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3454577A (en) * | 1965-11-09 | 1969-07-08 | Hoffmann La Roche | 4-(1,2,3,4,5,6,7,8 - octahydro - 1,8 - dioxo-9-acridanyl) - benzenesulfonamide and derivatives |
| DE2003148A1 (de) * | 1970-01-24 | 1971-07-29 | Bayer Ag | Neue 1,4-Dihydropyridinderivate |
| DE2018738A1 (en) * | 1970-04-18 | 1971-10-28 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Hydrogenated pyridines, quinolines andacridi |
| US4021434A (en) * | 1972-01-22 | 1977-05-03 | Yamanouchi Pharmaceutical Co., Ltd. | Sodium β-[2,6-dimethyl-3,5-bis(ethoxycarbonyl)-4-(3-nitrophenyl)-1,4-dihydropyridine-1-yl]ethyl sulfate |
| DE2242106A1 (de) * | 1972-08-26 | 1974-03-21 | Agfa Gevaert Ag | Lichtempfindliches photographisches material |
| DE2718130C2 (de) * | 1977-04-23 | 1979-05-17 | Du Pont De Nemours (Deutschland) Gmbh, 4000 Duesseldorf | lichtempfindliches Aufzeichnungsmaterial |
| US4546186A (en) * | 1983-12-14 | 1985-10-08 | American Home Products Corporation | 1,4,5,6,7,8-Hexahydro-2-methyl-5-oxo-4-(2-thiazolyl)-3-quinoline carboxylic acid 2-methyl(phenylmethyl)amino ethyl ester and pharmaceutically acceptable salts |
-
1992
- 1992-09-30 GB GB929220570A patent/GB9220570D0/en active Pending
- 1992-10-20 NO NO924066A patent/NO178696C/no unknown
- 1992-10-20 AT AT92309566T patent/ATE152103T1/de not_active IP Right Cessation
- 1992-10-20 KR KR1019920019226A patent/KR930007907A/ko not_active Application Discontinuation
- 1992-10-20 FI FI924744A patent/FI924744A/fi not_active Application Discontinuation
- 1992-10-20 HU HU9203288A patent/HUT65626A/hu unknown
- 1992-10-20 MY MYPI92001895A patent/MY106661A/en unknown
- 1992-10-20 TW TW081108329A patent/TW223061B/zh active
- 1992-10-20 EP EP92309566A patent/EP0539153B1/en not_active Expired - Lifetime
- 1992-10-20 US US07/963,798 patent/US5258390A/en not_active Expired - Lifetime
- 1992-10-20 IL IL92103478A patent/IL103478A0/xx unknown
- 1992-10-20 PL PL92296229A patent/PL169716B1/pl unknown
- 1992-10-20 NZ NZ244822A patent/NZ244822A/en unknown
- 1992-10-20 CZ CS923175A patent/CZ317592A3/cs unknown
- 1992-10-20 CA CA002080950A patent/CA2080950A1/en not_active Abandoned
- 1992-10-20 DE DE69219271T patent/DE69219271T2/de not_active Expired - Fee Related
- 1992-10-20 AU AU27139/92A patent/AU659500B2/en not_active Ceased
- 1992-10-20 JP JP28186292A patent/JP3157924B2/ja not_active Expired - Fee Related
- 1992-10-20 DE DE69223736T patent/DE69223736T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US5258390A (en) | 1993-11-02 |
| AU2713992A (en) | 1993-04-22 |
| DE69223736D1 (de) | 1998-02-05 |
| KR930007907A (ko) | 1993-05-20 |
| FI924744A0 (fi) | 1992-10-20 |
| ATE152103T1 (de) | 1997-05-15 |
| HU9203288D0 (en) | 1992-12-28 |
| JP3157924B2 (ja) | 2001-04-23 |
| GB9220570D0 (en) | 1992-11-11 |
| AU659500B2 (en) | 1995-05-18 |
| DE69223736T2 (de) | 1998-05-07 |
| EP0539153B1 (en) | 1997-04-23 |
| DE69219271D1 (de) | 1997-05-28 |
| MY106661A (en) | 1995-07-31 |
| DE69219271T2 (de) | 1997-08-07 |
| NO924066L (no) | 1993-04-22 |
| CA2080950A1 (en) | 1993-04-22 |
| PL296229A1 (en) | 1993-10-04 |
| CZ317592A3 (en) | 1993-05-12 |
| PL169716B1 (pl) | 1996-08-30 |
| NZ244822A (en) | 1994-10-26 |
| JPH05201986A (ja) | 1993-08-10 |
| NO178696B (no) | 1996-02-05 |
| NO924066D0 (no) | 1992-10-20 |
| HUT65626A (en) | 1994-07-28 |
| FI924744A (fi) | 1993-04-22 |
| NO178696C (no) | 1996-05-15 |
| TW223061B (en) | 1994-05-01 |
| EP0539153A1 (en) | 1993-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL103478A0 (en) | Therapeutic agent | |
| CA2263561A1 (en) | Thienopyrimidines | |
| CA2125888A1 (en) | Pharmaceutically active antioxidant containing composition and the method of its use to prevent and treat restenosis following angioplasty | |
| IL102626A0 (en) | Therapeutic amides | |
| EP0731712A4 (en) | PHYSIOLOGICAL STABILIZED BUTTERIC ACID PREPARATIONS, AND BUTTERIC ACIDS AND DERIVATIVES AS ANTINEOPLASTIC ACTIVE SUBSTANCE | |
| TW273550B (fi) | ||
| MY103352A (en) | Piperazinyl-heterocyclic compounds | |
| HK1015137A1 (en) | Antiviral 4-substituted-2-deoxy-2,3-didehydro derivatives of alpha d-neuraminic acid | |
| ZA921292B (en) | Treatment of lower urinary tract disorders. | |
| ATE161531T1 (de) | Acridine-1,8-dionderivate als therapeutisches mittel | |
| IL100701A0 (en) | Malic acid derivatives and compositions for the treatment of psoriasis | |
| MY103210A (en) | Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds. | |
| HU9500262D0 (en) | New pharmaceutical compositions containing 3-phenyl-sulfonyl-3,7-diazabicyclo[3.3.1]nonane compounds | |
| HU9400908D0 (en) | Pharmaceutical compositions for treatng skin disorders | |
| TW349864B (en) | Use of N-(pyridinyl)-1H-indol-a-amines for the preparation of a medicament for the treatment of obsessive-compulsive disorders | |
| GR3025797T3 (en) | New carboxylic-acid esters of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, the preparation of such esters and their use | |
| EP0246573A3 (en) | Pharmaceutical composition containing a 8-chlorobenzothiazepine compound and its use | |
| IL85231A0 (en) | Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones,a process for the preparation thereof,pharmaceutical compositions containing same and the use thereof | |
| MX9205778A (es) | Agente terapeutico. | |
| EP0987022A4 (en) | PREVENTIVE AND HEALING MEDICINES FOR ULCERATIVE KOLITIS AND / OR MORBUS CROHN | |
| WO1999005106A8 (fr) | Nouveaux derives benzamides stimulants de la motricite gastrointestinale haute et basse | |
| IT1262567B (it) | Pirrolidin-2-oni,loro preparazione,composizioni farmaceutiche che li contengono e loro uso in terapia. | |
| RU92004356A (ru) | Производные 1,8-акридиндиона, полезные как терапевтическое средство для лечения недержания мочи, и способ его получения |